NEW YORK STEM CELL FOUNDATION INC (EIN 202905531) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

JEFFREY WALLERSTEIN

Phone

2123657428

Tax Period

2023-07-01 to 2024-06-30

NEW YORK STEM CELL FOUNDATION INC, founded in 2005, is a mid-sized nonprofit in the Medical Research sector that reported $23.1M in total revenue in fiscal year 2023. Revenue fell 24% from the prior year — a significant decline worth monitoring. Expenses of $44.4M exceeded revenue, resulting in a 93% operating deficit.

Mission

THE NEW YORK STEM CELL FOUNDATION ("NYSCF") IS A NOT-FOR-PROFIT ORGANIZATION THAT WAS INCORPORATED IN THE STATE OF NEW YORK ON MAY 19, 2005. NYSCF'S MISSION IS TO ACCELERATE CURES FOR THE MAJOR DISEASES OF OUR TIME THROUGH STEM CELL RESEARCH. NYSCF PROGRAMS INCLUDE: 1) NYSCF RESEARCH - SUPPORTING AND ENABLING THE UNRESTRICTED PURSUIT OF THE MOST ADVANCED STEM CELL RESEARCH, BOTH IN OUR OWN LABORATORY AND THROUGH COLLABORATIONS WITH MAJOR MEDICAL RESEARCH INSTITUTIONS; 2) NYSCF FELLOWSHIP AND INNOVATOR PROGRAMS - SUPPORTING AND TRAINING THE NEXT GENERATION OF SCIENTISTS, BOTH AT THE POST-DOCTORAL LEVEL AS FELLOWS, AND AS INVESTIGATORS PURSUING INNOVATIVE WORK THAT TRANSLATES RESEARCH INTO CURES; 3) NYSCF CONFERENCE AND SYMPOSIA - CONVENING THE PRE-EMINENT ANNUAL TRANSLATIONAL STEM CELL RESEARCH CONFERENCE AND AN ON-GOING SERIES OF PROGRAMS FOR SCIENTISTS, POLICYMAKERS AND THE PUBLIC.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $23,317,267

Program Service Revenue $0

Investment Income $104,026

Other Revenue $-358,230

TOTAL REVENUE $23,063,063

Expense Breakdown

Grants Paid $8,505,691

Salaries & Benefits $18,306,600

Fundraising Expenses $1,729,070

Program Expenses $40,557,136

Other Expenses $17,595,305

TOTAL EXPENSES $44,407,596

Year-over-Year Comparison

	2023	2022	Change
Revenue	$23,063,063	$30,392,844	-0.2%
Expenses	$44,407,596	$43,475,154	+0.0%
Net Income	$-21,344,533	$-13,082,310	+0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

164

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$636,815

Total Directors

Key Employees

$1,757,831

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROY GERONEMUS	CHAIRMAN & DIRECTOR	6.00	Officer Director	$0	$0	$0
MARGO ALEXANDER	TREASURER & DIRECTOR	6.00	Officer Director	$0	$0	$0
DERRICK ROSSI	DIRECTOR & ACTING CEO (UNTIL 1/7/24)	3.00	Director	$0	$0	$0
KAREN BURKE	DIRECTOR	3.00	Director	$0	$0	$0
FRANCESCO CLARK	DIRECTOR	3.00	Director	$0	$0	$0
RICHARD J MASSEY	DIRECTOR	3.00	Director	$0	$0	$0
PAUL GOLDBERGER	DIRECTOR	3.00	Director	$0	$0	$0
PAUL M MEISTER	DIRECTOR	3.00	Director	$0	$0	$0
SIDDHARTHA MUKHERJEE	DIRECTOR	3.00	Director	$0	$0	$0
STEPHEN M ROSS	DIRECTOR	3.00	Director	$0	$0	$0
KAY UNGER	DIRECTOR	3.00	Director	$0	$0	$0
STEPHEN M SCHERR	DIRECTOR	3.00	Director	$0	$0	$0
CLYDE WILLIAMS	DIRECTOR	3.00	Director	$0	$0	$0
MARILYN BRESLOW	DIRECTOR	3.00	Director	$0	$0	$0
GEORGE LAZARUS	DIRECTOR	3.00	Director	$0	$0	$0
PEGGY BRIM	DIRECTOR	3.00	Director	$0	$0	$0
JENNIFER RAAB SEE SCH O	PRESIDENT AND CEO (1/8/24)	40.00	Officer	$0	$0	$0
JEFFREY WALLERSTEIN	CFO & COO	40.00	Officer	$601,218	$35,597	$636,815
DANIEL PAULL	VICE PRESIDENT, STEM CELL TECHNOLOGY PLATFORMS	40.00	Key Emp	$372,378	$42,464	$414,842
FREDERICK MONSMA	SENIOR VICE PRESIDENT, SCIENTIFIC OPERATIONS	40.00	Key Emp	$317,695	$27,462	$345,157
CHRISTINE LIN	CHIEF ADVANCEMENT OFFICER	40.00	Key Emp	$314,283	$27,737	$342,020
SIMI AHMED	SENIOR VICE PRESIDENT, STRATEGIC PARTNERSHIPS	40.00	Key Emp	$295,196	$33,489	$328,685
SCOTT NOGGLE	SENIOR VICE PRESIDENT, RESEARCH	40.00	Key Emp	$288,010	$39,117	$327,127

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$23,063,063	$44,407,596	$82,924,502	$-21,344,533
2023	$30,392,844	$43,475,154	$93,436,824	$-13,082,310
2022	$37,512,270	$41,703,809	$68,785,441	$-4,191,539
2021	$43,590,530	$39,653,628	$75,950,014	$3,936,902
2020	$21,611,522	$35,275,751	$70,013,247	$-13,664,229
2019	$40,135,955	$30,505,141	$82,378,860	$9,630,814
2018	$38,002,117	$29,092,019	$71,398,151	$8,910,098

NEW YORK STEM CELL FOUNDATION INC